AZATHIOPRINE-50 TABLET

מדינה: קנדה

שפה: אנגלית

מקור: Health Canada

מרכיב פעיל:

AZATHIOPRINE

זמין מ:

PRO DOC LIMITEE

קוד ATC:

L04AX01

INN (שם בינלאומי):

AZATHIOPRINE

כמות:

50MG

טופס פרצבטיות:

TABLET

הרכב:

AZATHIOPRINE 50MG

מסלול נתינה (של תרופות):

ORAL

יחידות באריזה:

100

סוג מרשם:

Prescription

איזור תרפויטי:

IMMUNOSUPPRESSIVE AGENTS

leaflet_short:

Active ingredient group (AIG) number: 0101830001; AHFS:

מצב אישור:

CANCELLED POST MARKET

תאריך אישור:

2023-07-10

מאפייני מוצר

PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
PR
AZATHIOPRINE-50
AZATHIOPRINE TABLETS USP
50 MG
IMMUNOSUPPRESSIVE AGENT
PRO DOC LTÉE
Date of Revision:
2925, Boul. Industriel,
February 11, 2020
Laval, Quebec
H7L 3W9
Submission Control No.: 235658
_AZATHIOPRINE-50 Product Monograph _
_ _
Page 2 of 29
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
............................................................................
3
SUMMARY PRODUCT INFORMATION
..................................................................................................
3
INDICATIONS AND CLINICAL USE
........................................................................................................
3
CONTRAINDICATIONS
.............................................................................................................................
3
WARNINGS AND PRECAUTIONS
............................................................................................................
4
ADVERSE REACTIONS
..............................................................................................................................
9
DRUG INTERACTIONS
............................................................................................................................
11
DOSAGE AND ADMINISTRATION
........................................................................................................
12
OVERDOSAGE
..........................................................................................................................................
13
ACTION AND CLINICAL PHARMACOLOGY
......................................................................................
13
STORAGE AND STABILITY
....................................................................................................................
15
SPECIAL HANDLING INSTRUCTIONS
.................................................................................................
15
DOSAGE FORMS, COMPOSITION AND PACKAGING
..................................